Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Jun-24 6:22 PM View:  | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 167% 2.0K to 5.35K | |
| 18-Jun-24 4:51 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 1% 900.06K to 910.2K | |
| 21-Jun-23 6:25 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 02-Jun-23 7:13 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 31-May-23 | Grant | 4,375 | -- | -- | < 1% 895.68K to 900.06K | |
| 03-Jun-22 4:57 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Jun-22 | Grant | 4,312 | -- | -- | < 1% 891.37K to 895.68K | |
| 28-Jun-21 4:11 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 25-Jun-21 | Market Sale (Planned) | 6,755 | $27.50 | $185,762.00 | (< 1%) 898.13K to 891.37K | < 1% |
| 28-Jun-21 4:11 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 24-Jun-21 | Market Sale (Planned) | 729 | $27.50 | $20,047.50 | (< 1%) 898.86K to 898.13K | < 1% |
| 23-Jun-21 5:47 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 21-Jun-21 | Market Sale (Planned) | 2,516 | $27.50 | $69,190.00 | (< 1%) 901.37K to 898.86K | 4% |
| 03-Jun-21 4:39 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Jun-21 | Market Sale (Planned) | 10,000 | $27.50 | $275,000.00 | (1%) 911.37K to 901.37K | 3% |
| 22-Apr-21 8:17 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 20-Apr-21 | Market Sale (Planned) | 10,000 | $28.06 | $280,568.00 | (1%) 921.37K to 911.37K | (8%) |
| 24-Mar-21 11:33 AM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 22-Mar-21 | Market Sale (Planned) | 10,000 | $31.10 | $311,021.00 | (1%) 931.37K to 921.37K | 4% |
| 24-Feb-21 3:33 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 22-Feb-21 | Market Sale (Planned) | 10,000 | $35.52 | $355,191.00 | (1%) 941.37K to 931.37K | (< 1%) |
| 02-Feb-21 7:39 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Feb-21 | Market Sale (Planned) | 9,949 | $33.25 | $330,804.00 | (1%) 951.32K to 941.37K | (7%) |
| 02-Feb-21 7:39 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 29-Jan-21 | Market Sale (Planned) | 51 | $27.50 | $1,402.50 | (< 1%) 951.37K to 951.32K | (29%) |
| 04-Feb-20 6:26 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Feb-20 | Conversion | 37,486 | -- | -- | 4% 863.9K to 901.39K | |
| 04-Feb-20 6:26 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Feb-20 | Conversion | 49,981 | -- | -- | 6% 901.39K to 951.37K | |
| 04-Jun-19 2:41 PM View: | Teligent, Inc. (TLGT) | 03-Jun-19 | Market Purchase | 10,000 | $0.70 | $7,005.00 | 100% 0 to 10.0K | (98%) |
| 20-Oct-10 5:49 PM View: | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 333,438 | -- | -- | (100%) 333.44K to 0 | |
| 11-Dec-09 3:32 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Dec-09 | Grant | 6,910 | -- | -- | 6% 110.39K to 117.3K | |
| 23-Nov-09 6:36 PM View: | Valeant Pharmaceuticals Int... (VRX) | 20-Nov-09 | Market Purchase | 3,000 | $33.31 | $99,928.20 | 3% 104.01K to 107.01K | 75% |
| 19-Nov-09 1:50 PM View: | Valeant Pharmaceuticals Int... (VRX) | 18-Nov-09 | Market Purchase | 2,385 | $33.58 | $80,097.10 | 2% 101.63K to 104.01K | 73% |
| 12-Nov-09 3:39 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Nov-09 | Market Purchase | 1,525 | $32.81 | $50,039.20 | 2% 100.1K to 101.63K | 77% |
| 14-Sep-09 2:57 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Sep-09 | Grant | 3,373 | -- | -- | 3% 100.1K to 103.47K | |
| 11-Dec-09 3:32 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Sep-09 | Grant Duplicate | 3,373 | -- | -- | 3% 107.01K to 110.39K | |
| 17-Aug-09 3:05 PM View: | Valeant Pharmaceuticals Int... (VRX) | 14-Aug-09 | Market Purchase | 3,373 | $26.69 | $90,026.40 | 3% 96.73K to 100.1K | 118% |
| 11-Jun-09 6:28 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Jun-09 | Grant | 6,010 | -- | -- | 7% 90.72K to 96.73K | |
| 26-May-09 7:51 PM View: | Valeant Pharmaceuticals Int... (VRX) | 26-May-09 | Market Purchase | 1,352 | $22.19 | $30,000.90 | 2% 89.37K to 90.72K | 164% |
| 18-May-09 6:12 PM View: | Valeant Pharmaceuticals Int... (VRX) | 18-May-09 | Market Purchase | 1,360 | $22.06 | $30,001.60 | 2% 88.01K to 89.37K | 166% |
| 12-May-09 2:37 PM View: | Valeant Pharmaceuticals Int... (VRX) | 11-May-09 | Purchase | 1,538 | $19.50 | $29,991.00 | 2% 83.03K to 84.57K | |
| 04-May-09 5:06 PM View: | Valeant Pharmaceuticals Int... (VRX) | 04-May-09 | Market Purchase | 1,760 | $17.05 | $30,008.00 | 2% 81.27K to 83.03K | 242% |
| 27-Apr-09 5:14 PM View: | Valeant Pharmaceuticals Int... (VRX) | 27-Apr-09 | Market Purchase | 1,732 | $17.32 | $29,998.20 | 2% 79.54K to 81.27K | 237% |
| 21-Apr-09 8:01 PM View: | Valeant Pharmaceuticals Int... (VRX) | 20-Apr-09 | Market Purchase | 1,703 | $17.62 | $30,006.90 | 2% 77.84K to 79.54K | 231% |
| 20-Mar-09 1:53 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Mar-09 | Grant | 77,839 | -- | -- | 100% 0 to 77.84K |